Apellis Pharmaceuticals is a Biopharmaceutical company that is committed to leveraging courageous science, creativity and compassion to deliver life changing therapies. The company develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade including those within hematology, ophthalmology, nephrology and neurology. The headquarters is in USA.
World Top 500 Companies by Revenue as of 2023
- Rank by Revenue in Search Criteria: 4941Annual Revenue in USD: 75 Million USDAnnual Net Income in USD: -652 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 3,727Market Cap (Jul-30-2023): 4 Billion USDEmployee Count: 767Employee Count as of Date: As on 2022Company Profile:
- Rank by Revenue in Search Criteria: 4942Annual Revenue in USD: 71 Million USDAnnual Net Income in USD: -59 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 4,888Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: Employee Count as of Date: Company Profile:Morphic Holding is a Biopharmaceutical company leading the development of a new generation of oral integrin drugs and a unique integrin discovery platform. It is having 76 employees as on 2019. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 4943Annual Revenue in USD: 60 Million USDAnnual Net Income in USD: 29 Million USDAnnual Results for Period Ending: Dec-2021 ending yearWorld Rank (Jul-30-2023): 4,872Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: 264Employee Count as of Date: As on 2020Company Profile:
- Rank by Revenue in Search Criteria: 4944Annual Revenue in USD: 56 Million USDAnnual Net Income in USD: -643 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 2,847Market Cap (Jul-30-2023): 5 Billion USDEmployee Count: 797Employee Count as of Date: As on 2022Company Profile:Bio-pharmaceutical company with headquarters is in Denmark.
- Rank by Revenue in Search Criteria: 4945Annual Revenue in USD: 55 Million USDAnnual Net Income in USD: -845 Million USDAnnual Results for Period Ending: Mar-2022 ending yearWorld Rank (Jul-30-2023): 2,004Market Cap (Jul-30-2023): Employee Count: Employee Count as of Date: Company Profile:
Roivant Sciences is biopharmaceutical and health technology companies. Headquarters is in Switzerland.
- Rank by Revenue in Search Criteria: 4946Annual Revenue in USD: 52 Million USDAnnual Net Income in USD: -474 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 3,722Market Cap (Jul-30-2023): 4 Billion USDEmployee Count: 312Employee Count as of Date: As on 2021Company Profile:
Intellia Therapeutics is a Biotechnology company. The company annual revenue is 43.2 million USD, total assets is 334.2 million USD and 211 employees as on 2019. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 4947Annual Revenue in USD: 50 Million USDAnnual Net Income in USD: -187 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 3,778Market Cap (Jul-30-2023): 4 Billion USDEmployee Count: 108Employee Count as of Date: As on 2021Company Profile:
Axsome Therapeutics is a biopharmaceutical company. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 4948Annual Revenue in USD: 50 Million USDAnnual Net Income in USD: Annual Results for Period Ending: Dec-2019 ending yearWorld Rank (Jul-30-2023): 4,346Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: Employee Count as of Date: Company Profile:
Capital & Counties Properties is a Property Investment and Development company. The company sale of its interests in Earls Court for £425 million and net assets £2.5bn. The headquarters is in UK, South Africa.
- Rank by Revenue in Search Criteria: 4949Annual Revenue in USD: 49 Million USDAnnual Net Income in USD: 717 Million USDAnnual Results for Period Ending: Dec-2021 ending yearWorld Rank (Jul-30-2023): 4,421Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: Employee Count as of Date: Company Profile:
VGP NV develops, manages and owns high quality logistics and semi industrial real estate company. It operate a fully integrated business model with capabilities and long standing expertise across the value chain from land acquisition to development and asset and property management. The headquarters is in Belgium.
- Rank by Revenue in Search Criteria: 4950Annual Revenue in USD: 42 Million USDAnnual Net Income in USD: 1 Million USDAnnual Results for Period Ending: Jan-2021 ending yearWorld Rank (Jul-30-2023): 4,100Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: Employee Count as of Date: Company Profile:
The company business is Reconstruction of the places adjacent to the Grand Mosque in Mecca. Owning, developing, managing, investing, purchasing and leasing properties adjacent to the Grand Mosque.
Ads